Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
s Annual Report on Form10-K and its most recent Quarterly Report on Form 10-Q. SangamoBioSciences Inc. assumes no obligation to update the forward-lookinginformation contained in this press release.
Date:11/10/2008